Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin

Type-2 Diabetes Mellitus Clinical Trial

Official title:
A Local Phase IV, Multicenter, Open-label Study to Evaluate Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin

Status Completed

Clinical Trial Summary

The purpose of this study is to observe change of HbA1c over time from baseline to month 12. The ultimate goal of this study is to provide a local reference value to the physicians & patients in the future when they consider initiating Vildagliptin and taking balance between efficacy, compliance, risk factors, convenience and medication cost.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01766778
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	Phase 4
Start date	May 2013
Completion date	October 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01818310` - Safety and Efficacy Study of Autologous Bone Marrow Aspirate Concentrate for No-Option Critical Limb Ischemia	Phase 2/Phase 3
Completed	`NCT01472614` - Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes Mellitus	Phase 3
Completed	`NCT01823510` - Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients	Phase 4
Not yet recruiting	`NCT05380817` - Stanford Kids CAMP Study	N/A
Terminated	`NCT02671331` - Loop Duodenal Switch Surgery in Morbidly Obese Patients	N/A
Recruiting	`NCT01422057` - Risk Prediction in Type II Diabetics With Ischemic Heart Disease	N/A
Completed	`NCT02693392` - Clinical Evaluation of Fenugreek Seed Extract, a Nutraceutical in Patients With Type- 2 Diabetes	N/A